Exact Mass: 511.1387

Exact Mass Matches: 511.1387

Found 145 metabolites which its exact mass value is equals to given mass value 511.1387, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

3-Methyl-1-hydroxybutyl-ThPP

3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-{[hydroxy(phosphonooxy)phosphoryl]oxy}ethyl)-2-(1-hydroxy-3-methylbutyl)-4-methyl-1,3-thiazol-3-ium

C17H29N4O8P2S+ (511.1181)

3-Methyl-1-hydroxybutyl-ThPP is an intermediate in valine, leucine and isoleucine degradation(KEGG ID C15974). It is the second to last step in the synthesis of 3-methylbutanoyl-CoA and is converted from 4-methyl-2-oxopentanoate via the enzyme 2-oxoisovalerate dehydrogenase [EC:1.2.4.4]. It is then converted to S-(3-methylbutanoyl)-dihydrolipoamide-E via the enzyme 2-oxoisovalerate dehydrogenase [EC:1.2.4.4]. [HMDB] 3-Methyl-1-hydroxybutyl-ThPP is an intermediate in valine, leucine and isoleucine degradation(KEGG ID C15974). It is the second to last step in the synthesis of 3-methylbutanoyl-CoA and is converted from 4-methyl-2-oxopentanoate via the enzyme 2-oxoisovalerate dehydrogenase [EC:1.2.4.4]. It is then converted to S-(3-methylbutanoyl)-dihydrolipoamide-E via the enzyme 2-oxoisovalerate dehydrogenase [EC:1.2.4.4].

2-Methyl-1-hydroxybutyl-ThPP

3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-{[hydroxy(phosphonooxy)phosphoryl]oxy}ethyl)-2-[(2S)-1-hydroxy-2-methylbutyl]-4-methyl-1,3-thiazol-3-ium

C17H29N4O8P2S+ (511.1181)

2-Methyl-1-hydroxybutyl-ThPP is an intermediate in Valine, leucine and isoleucine degradation. 2-Methyl-1-hydroxybutyl-ThPP is the second to last step for the synthesis of (S)-2-Methylbutanoyl-CoA. 2-Methyl-1-hydroxybutyl-ThPP is converted from (S)-3-Methyl-2-oxopentanoic acid via the enzyme 2-oxoisovalerate dehydrogenase E1 component, alpha subunit(EC 1.2.4.4). It is then converted to S-(2-Methylbutanoyl)-dihydrolipoamide-E via the same enzyme. 2-Methyl-1-hydroxybutyl-ThPP is an intermediate in Valine, leucine and isoleucine degradation. 2-Methyl-1-hydroxybutyl-ThPP is the second to last step for the synthesis of (S)-2-Methylbutanoyl-CoA. 2-Methyl-1-hydroxybutyl-ThPP is converted

Hygromycin A

C2-epi-Hygromycin A

C23H29NO12 (511.169)

A natural product found in Streptomyces species.

Uzel (TN)

Leucovorin calcium (USP)

C20H21N7O7. Ca (511.1128)

V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AF - Detoxifying agents for antineoplastic treatment D020011 - Protective Agents > D000931 - Antidotes C2140 - Adjuvant > C2078 - Folic Acid Derivative D018977 - Micronutrients > D014815 - Vitamins Therapeutic category: 3929 Levoleucovorin Calcium (Calcium levofolinate), a levo isoform of Leucovorin Calcium (HY-13664), possesses antineoplastic effects. Levoleucovorin Calcium is also an augmentor of 5-fluorouracil (HY-90006) cytotoxicity against cancer[1][2].

Cefetamet pivoxyl

{7-[2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carbonyloxy}methyl 2,2-dimethylpropanoate

C20H25N5O7S2 (511.1195)

2-Biphenyl-4-yl-1-(1H-tetrazol-5-yl)ethylaminoethyl phosphonic acid

diphenyl {[(2-{[1,1-biphenyl]-4-yl}-1-(2H-1,2,3,4-tetrazol-5-yl)ethyl)amino]methyl}phosphonate

C28H26N5O3P (511.1773)

Hygromycin A

3-{4-[(5-acetyl-3,4-dihydroxyoxolan-2-yl)oxy]-3-hydroxyphenyl}-2-methyl-N-(4,6,7-trihydroxy-hexahydro-2H-1,3-benzodioxol-5-yl)prop-2-enimidate

C23H29NO12 (511.169)

3-acetyl-3,12-dihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxyhexopyranoside

C27H29NO9 (511.1842)

Cys Cys Met Arg

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-5-carbamimidamidopentanoic acid

C17H33N7O5S3 (511.1705)

Cys Cys Arg Met

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-4-(methylsulfanyl)butanoic acid

C17H33N7O5S3 (511.1705)

Cys Cys Thr Trp

(2S)-2-[(2S,3R)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-(1H-indol-3-yl)propanoic acid

C21H29N5O6S2 (511.1559)

Cys Cys Trp Thr

(2S,3R)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-hydroxybutanoic acid

C21H29N5O6S2 (511.1559)

Cys Asp Phe Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carboxypropanamido]-3-phenylpropanamido]-4-carbamoylbutanoic acid

C21H29N5O8S (511.1737)

Cys Asp Gln Phe

(3S)-3-[(2R)-2-amino-3-sulfanylpropanamido]-3-{[(1S)-3-carbamoyl-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propyl]carbamoyl}propanoic acid

C21H29N5O8S (511.1737)

Cys Glu Phe Asn

(4S)-4-[(2R)-2-amino-3-sulfanylpropanamido]-4-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Cys Glu Asn Phe

(4S)-4-[(2R)-2-amino-3-sulfanylpropanamido]-4-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Cys Phe Asp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-3-carboxypropanamido]-4-carbamoylbutanoic acid

C21H29N5O8S (511.1737)

Cys Phe Glu Asn

(4S)-4-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Cys Phe Asn Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-3-carbamoylpropanamido]pentanedioic acid

C21H29N5O8S (511.1737)

Cys Phe Gln Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-4-carbamoylbutanamido]butanedioic acid

C21H29N5O8S (511.1737)

Cys Met Cys Arg

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C17H33N7O5S3 (511.1705)

Cys Met Met Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoic acid

C18H33N5O6S3 (511.1593)

Cys Met Gln Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoic acid

C18H33N5O6S3 (511.1593)

Cys Met Arg Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C17H33N7O5S3 (511.1705)

Cys Asn Glu Phe

(4S)-4-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Cys Asn Phe Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-phenylpropanamido]pentanedioic acid

C21H29N5O8S (511.1737)

Cys Gln Asp Phe

(3S)-3-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C21H29N5O8S (511.1737)

Cys Gln Phe Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-phenylpropanamido]butanedioic acid

C21H29N5O8S (511.1737)

Cys Gln Met Met

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid

C18H33N5O6S3 (511.1593)

Cys Arg Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C17H33N7O5S3 (511.1705)

Cys Arg Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C17H33N7O5S3 (511.1705)

Cys Thr Cys Trp

(2S)-2-[(2R)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C21H29N5O6S2 (511.1559)

Cys Thr Trp Cys

(2R)-2-[(2S)-2-[(2S,3R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C21H29N5O6S2 (511.1559)

Cys Trp Cys Thr

(2S,3R)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C21H29N5O6S2 (511.1559)

Cys Trp Thr Cys

(2R)-2-[(2S,3R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C21H29N5O6S2 (511.1559)

Asp Cys Phe Gln

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]-4-carbamoylbutanoic acid

C21H29N5O8S (511.1737)

Asp Cys Gln Phe

(3S)-3-amino-3-{[(1R)-1-{[(1S)-3-carbamoyl-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propyl]carbamoyl}-2-sulfanylethyl]carbamoyl}propanoic acid

C21H29N5O8S (511.1737)

Asp Phe Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C21H29N5O8S (511.1737)

Asp Phe Gln Cys

(3S)-3-amino-3-{[(1S)-1-{[(1S)-3-carbamoyl-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C21H29N5O8S (511.1737)

Asp Gln Cys Phe

(3S)-3-amino-3-{[(1S)-3-carbamoyl-1-{[(1R)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}propyl]carbamoyl}propanoic acid

C21H29N5O8S (511.1737)

Asp Gln Phe Cys

(3S)-3-amino-3-{[(1S)-3-carbamoyl-1-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-phenylethyl]carbamoyl}propyl]carbamoyl}propanoic acid

C21H29N5O8S (511.1737)

Glu Cys Phe Asn

(4S)-4-amino-4-{[(1R)-1-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-phenylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Glu Cys Asn Phe

(4S)-4-amino-4-{[(1R)-1-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}ethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Glu Phe Cys Asn

(4S)-4-amino-4-{[(1S)-1-{[(1R)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Glu Phe Asn Cys

(4S)-4-amino-4-{[(1S)-1-{[(1S)-2-carbamoyl-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Glu Asn Cys Phe

(4S)-4-amino-4-{[(1S)-2-carbamoyl-1-{[(1R)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Glu Asn Phe Cys

(4S)-4-amino-4-{[(1S)-2-carbamoyl-1-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-phenylethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Phe Cys Asp Gln

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-3-carboxypropanamido]-4-carbamoylbutanoic acid

C21H29N5O8S (511.1737)

Phe Cys Glu Asn

(4S)-4-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Phe Cys Asn Glu

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]pentanedioic acid

C21H29N5O8S (511.1737)

Phe Cys Gln Asp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]butanedioic acid

C21H29N5O8S (511.1737)

Phe Asp Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carboxypropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C21H29N5O8S (511.1737)

Phe Asp Gln Cys

(3S)-3-[(2S)-2-amino-3-phenylpropanamido]-3-{[(1S)-3-carbamoyl-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propyl]carbamoyl}propanoic acid

C21H29N5O8S (511.1737)

Phe Glu Cys Asn

(4S)-4-[(2S)-2-amino-3-phenylpropanamido]-4-{[(1R)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Phe Glu Asn Cys

(4S)-4-[(2S)-2-amino-3-phenylpropanamido]-4-{[(1S)-2-carbamoyl-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Phe Asn Cys Glu

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]pentanedioic acid

C21H29N5O8S (511.1737)

Phe Asn Glu Cys

(4S)-4-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carbamoylpropanamido]-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Phe Gln Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]butanedioic acid

C21H29N5O8S (511.1737)

Phe Gln Asp Cys

(3S)-3-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-carbamoylbutanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C21H29N5O8S (511.1737)

Met Cys Cys Arg

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C17H33N7O5S3 (511.1705)

Met Cys Met Gln

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoic acid

C18H33N5O6S3 (511.1593)

Met Cys Gln Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoic acid

C18H33N5O6S3 (511.1593)

Met Cys Arg Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanoic acid

C17H33N7O5S3 (511.1705)

Met Met Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C18H33N5O6S3 (511.1593)

Met Met Gln Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C18H33N5O6S3 (511.1593)

Met Gln Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C18H33N5O6S3 (511.1593)

Met Gln Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C18H33N5O6S3 (511.1593)

Met Arg Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H33N7O5S3 (511.1705)

Asn Cys Glu Phe

(4S)-4-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Asn Cys Phe Glu

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]pentanedioic acid

C21H29N5O8S (511.1737)

Asn Glu Cys Phe

(4S)-4-[(2S)-2-amino-3-carbamoylpropanamido]-4-{[(1R)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Asn Glu Phe Cys

(4S)-4-[(2S)-2-amino-3-carbamoylpropanamido]-4-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Asn Phe Cys Glu

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]pentanedioic acid

C21H29N5O8S (511.1737)

Asn Phe Glu Cys

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-phenylpropanamido]-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid

C21H29N5O8S (511.1737)

Gln Cys Asp Phe

(3S)-3-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C21H29N5O8S (511.1737)

Gln Cys Phe Asp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]butanedioic acid

C21H29N5O8S (511.1737)

Gln Cys Met Met

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid

C18H33N5O6S3 (511.1593)

Gln Asp Cys Phe

(3S)-3-[(2S)-2-amino-4-carbamoylbutanamido]-3-{[(1R)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}propanoic acid

C21H29N5O8S (511.1737)

Gln Asp Phe Cys

(3S)-3-[(2S)-2-amino-4-carbamoylbutanamido]-3-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C21H29N5O8S (511.1737)

Gln Phe Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]butanedioic acid

C21H29N5O8S (511.1737)

Gln Phe Asp Cys

(3S)-3-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-phenylpropanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C21H29N5O8S (511.1737)

Gln Met Cys Met

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C18H33N5O6S3 (511.1593)

Gln Met Met Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C18H33N5O6S3 (511.1593)

Arg Cys Cys Met

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C17H33N7O5S3 (511.1705)

Arg Cys Met Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C17H33N7O5S3 (511.1705)

Arg Met Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H33N7O5S3 (511.1705)

Thr Cys Cys Trp

(2S)-2-[(2R)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C21H29N5O6S2 (511.1559)

Thr Cys Trp Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C21H29N5O6S2 (511.1559)

Thr Trp Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C21H29N5O6S2 (511.1559)

Trp Cys Cys Thr

(2S,3R)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-hydroxybutanoic acid

C21H29N5O6S2 (511.1559)

Trp Cys Thr Cys

(2R)-2-[(2S,3R)-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-3-hydroxybutanamido]-3-sulfanylpropanoic acid

C21H29N5O6S2 (511.1559)

Trp Thr Cys Cys

(2R)-2-[(2R)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-hydroxybutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C21H29N5O6S2 (511.1559)

Citicoline sodium salt

C14H26N4NaO11P2 (511.0971)

TG 100572 (Hydrochloride)

C26H27Cl2N5O2 (511.1542)

sodium 3-[[4-(benzoylethylamino)-2-methylphenyl]azo]-4-hydroxynaphthalene-1-sulphonate

C26H22N3NaO5S (511.1178)

Tetrodotoxin citrate

C17H25N3O15 (511.1286)

Arzoxifene hydrochloride

C28H30ClNO4S (511.1584)

C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent

fmoc-3-(1-pyrenyl)-l-alanine

C34H25NO4 (511.1783)

Leucovorin Calcium

Folinic acid (Calcium)

C20H21CaN7O7 (511.1128)

V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AF - Detoxifying agents for antineoplastic treatment D020011 - Protective Agents > D000931 - Antidotes C2140 - Adjuvant > C2078 - Folic Acid Derivative D018977 - Micronutrients > D014815 - Vitamins Levoleucovorin Calcium (Calcium levofolinate), a levo isoform of Leucovorin Calcium (HY-13664), possesses antineoplastic effects. Levoleucovorin Calcium is also an augmentor of 5-fluorouracil (HY-90006) cytotoxicity against cancer[1][2].

[6-acetyloxy-5-(2,5-dioxopyrrol-1-yl)-3-oxospiro[2-benzofuran-1,9-xanthene]-3-yl] acetate

C28H17NO9 (511.0903)

Fmoc-Thr(HPO3Bzl)-OH

C26H26NO8P (511.1396)

Fmoc-Tyr(PO3Me2)-OH

C26H26NO8P (511.1396)

Fmoc-Sec(Mob)-OH

C26H25NO5Se (511.0898)

Cefetamet Pivoxil

C20H25N5O7S2 (511.1195)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

(2-Amino-2-biphenylyl)(chloro)palladium - tris(2-methyl-2-propanyl)phosphine (1:1)

C24H37ClNPPd (511.1387)

6-Deoxydaunomycin

C27H29NO9 (511.1842)

(E)-CefetametPivoxil

C20H25N5O7S2 (511.1195)

7,10,13-Tri(carboxymethyl)-5,15-dioxo-4,7,10,13,16-pentaaza-1,19-dithianonadecane

C18H33N5O8S2 (511.177)

(E)-N-[(3aS,4R,5S,6S,7R,7aR)-4,6,7-trihydroxy-3a,4,5,6,7,7a-hexahydro-1,3-benzodioxol-5-yl]-3-[4-[(2S,3S,4S,5S)-5-acetyl-3,4-dihydroxyoxolan-2-yl]oxy-3-hydroxyphenyl]-2-methylprop-2-enamide

C23H29NO12 (511.169)

(E)-3-[4-(5-acetyl-3,4-dihydroxyoxolan-2-yl)oxy-3-hydroxyphenyl]-2-methyl-N-(4,6,7-trihydroxy-3a,4,5,6,7,7a-hexahydro-1,3-benzodioxol-5-yl)prop-2-enamide

C23H29NO12 (511.169)

2-[(3-cyano-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-2-yl)thio]-N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]acetamide

C24H25N5O4S2 (511.1348)

2,4-Dichloro-benzoic acid 2-{[4-(2,2-dimethyl-propionylamino)-benzoyl]-hydrazonomethyl}-phenyl ester

C26H23Cl2N3O4 (511.1066)

alpha-Kdo1Me-(2->8)-alpha-Kdo-OAll(1-)

C20H31O15- (511.1663)

3-Methyl-1-hydroxybutyl-TPP

3-Methyl-1-hydroxybutyl-ThPP

C17H29N4O8P2S+ (511.1181)

2-Methyl-1-hydroxybutyl-TPP

2-Methyl-1-hydroxybutyl-ThPP

C17H29N4O8P2S+ (511.1181)

ST 21:6;O7;Tau

C23H29NO10S (511.1512)

ST 22:5;O6;Tau

C24H33NO9S (511.1876)

CGP71683 hydrochloride

C26H30ClN5O2S (511.1809)

CGP71683 hydrochloride is a competitive neuropeptide Y5 receptor antagonist with a Ki of 1.3 nM, and shows no obvious activity at Y1 receptor (Ki, >4000 nM) and Y2 receptor (Ki, 200 nM) in cell membranes.

CVT-11127

C25H23Cl2N5O3 (511.1178)

CVT-11127 is a potent SCD inhibitor. CVT-11127 induces apoposis and arrests the cell cycle at the G1/S phase. CVT-11127 has the potential for the research of lung cancer[1]. CVT-11127 is a potent SCD inhibitor. CVT-11127 induces apoposis and arrests the cell cycle at the G1/S phase. CVT-11127 has the potential for the research of lung cancer[1].

PPTN (hydrochloride)

C29H25ClF3NO2 (511.1526)

PPTN hydrochloride is a potent, high-affinity, competitive and highly selective P2Y14 receptor antagonist with a KB value of 434 pM. PPTN hydrochloride exhibits no agonist or antagonist effect at the P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, or P2Y13 receptors. Anti-inflammatory and anti-immune activity[1].

(2e)-n-[(3ar,4s,5s,6r,7s,7as)-4,6,7-trihydroxy-hexahydro-2h-1,3-benzodioxol-5-yl]-3-(4-{[(2s,3s,4s,5s)-5-acetyl-3,4-dihydroxyoxolan-2-yl]oxy}-3-hydroxyphenyl)-2-methylprop-2-enimidic acid

C23H29NO12 (511.169)

(1s,11s,13s,14r,15s,16s)-15-hydroxy-14-methoxy-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-trien-16-yl 3,4-dimethoxybenzoate

C27H29NO9 (511.1842)

(5s,7r,8s,9r,10r,18r)-18-ethyl-9,10-dihydroxy-8-methoxy-7,23-dimethyl-4,6,19-trioxa-22-azahexacyclo[12.11.0.0³,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁷,²²]pentacosa-1(25),3(11),13,16,23-pentaene-2,12,15,20-tetrone

(5s,7r,8s,9r,10r,18r)-18-ethyl-9,10-dihydroxy-8-methoxy-7,23-dimethyl-4,6,19-trioxa-22-azahexacyclo[12.11.0.0³,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁷,²²]pentacosa-1(25),3(11),13,16,23-pentaene-2,12,15,20-tetrone

C26H25NO10 (511.1478)

(2e)-3-(4-{[(2s,3s,4s,5s)-5-acetyl-3,4-dihydroxyoxolan-2-yl]oxy}-3-hydroxyphenyl)-2-methyl-n-[(4r,5r,6s,7r)-4,6,7-trihydroxy-hexahydro-2h-1,3-benzodioxol-5-yl]prop-2-enimidic acid

C23H29NO12 (511.169)

1-[5-({[2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutylidene]amino}(carboxy)methyl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyimidazole-4-carboxylic acid

C20H25N5O11 (511.155)

(4r)-4-[(9'r,9'as)-1'-acetyl-9'-hydroxy-3'-oxo-9'ah-spiro[cyclopropane-1,2'-imidazo[1,2-a]indol]-9'-ylmethyl]-2-methyl-1-methylidene-4h-pyrazino[2,1-b]quinazoline-3,6-dione

C28H25N5O5 (511.1856)

(11r,15s,16s)-15-hydroxy-14-methoxy-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-trien-16-yl 3,4-dimethoxybenzoate

C27H29NO9 (511.1842)

8-acetyl-10-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-6,8-dihydroxy-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione

C27H29NO9 (511.1842)

ethyl (15r,16s,18r)-3,10,16-trihydroxy-15-methyl-5-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1¹⁵,¹⁸.0²,⁶.0⁷,²⁷.0⁸,¹³.0¹⁹,²⁶.0²⁰,²⁵]octacosa-1(26),2(6),3,7(27),8(13),9,11,20(25),21,23-decaene-16-carboxylate

ethyl (15r,16s,18r)-3,10,16-trihydroxy-15-methyl-5-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1¹⁵,¹⁸.0²,⁶.0⁷,²⁷.0⁸,¹³.0¹⁹,²⁶.0²⁰,²⁵]octacosa-1(26),2(6),3,7(27),8(13),9,11,20(25),21,23-decaene-16-carboxylate

C28H21N3O7 (511.1379)

(2e)-n-[(3ar,4s,5r,6r,7s,7as)-4,6,7-trihydroxy-hexahydro-2h-1,3-benzodioxol-5-yl]-3-(4-{[(2s,3s,4s,5s)-5-acetyl-3,4-dihydroxyoxolan-2-yl]oxy}-3-hydroxyphenyl)-2-methylprop-2-enimidic acid

C23H29NO12 (511.169)

3-{4-[(5-acetyl-3,4-dihydroxyoxolan-2-yl)oxy]-3-hydroxyphenyl}-2-methyl-n-(4,6,7-trihydroxy-hexahydro-2h-1,3-benzodioxol-5-yl)prop-2-enimidic acid

C23H29NO12 (511.169)

ethyl (15s,16s,18r)-3,10,16-trihydroxy-15-methyl-5-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1¹⁵,¹⁸.0²,⁶.0⁷,²⁷.0⁸,¹³.0¹⁹,²⁶.0²⁰,²⁵]octacosa-1(26),2(6),3,7(27),8(13),9,11,20(25),21,23-decaene-16-carboxylate

ethyl (15s,16s,18r)-3,10,16-trihydroxy-15-methyl-5-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1¹⁵,¹⁸.0²,⁶.0⁷,²⁷.0⁸,¹³.0¹⁹,²⁶.0²⁰,²⁵]octacosa-1(26),2(6),3,7(27),8(13),9,11,20(25),21,23-decaene-16-carboxylate

C28H21N3O7 (511.1379)

4-{1'-acetyl-9'-hydroxy-3'-oxo-9'ah-spiro[cyclopropane-1,2'-imidazo[1,2-a]indol]-9'-ylmethyl}-2-methyl-1-methylidene-4h-pyrazino[2,1-b]quinazoline-3,6-dione

C28H25N5O5 (511.1856)

8-acetyl-10-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-8,11-dihydroxy-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione

C27H29NO9 (511.1842)

(2e)-n-[(3as,4r,5r,6s,7r,7ar)-4,6,7-trihydroxy-hexahydro-2h-1,3-benzodioxol-5-yl]-3-(4-{[(2s,3s,4s,5s)-5-acetyl-3,4-dihydroxyoxolan-2-yl]oxy}-3-hydroxyphenyl)-2-methylprop-2-enimidic acid

C23H29NO12 (511.169)

1-[(2r,3r,4s,5r)-5-[(s)-{[(2s,3s,4r)-2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutylidene]amino}(carboxy)methyl]-3,4-dihydroxyoxolan-2-yl]-2-hydroxyimidazole-4-carboxylic acid

C20H25N5O11 (511.155)

18-ethyl-9,10-dihydroxy-8-methoxy-7,23-dimethyl-4,6,19-trioxa-22-azahexacyclo[12.11.0.0³,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁷,²²]pentacosa-1(25),3(11),13,16,23-pentaene-2,12,15,20-tetrone

C26H25NO10 (511.1478)

(8s,10r)-8-acetyl-10-{[(2s,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8-dihydroxy-1-methoxy-9,10-dihydro-7h-tetracene-5,12-dione

C27H29NO9 (511.1842)

(2e)-n-[(3as,4r,5r,6s,7r,7ar)-4,6,7-trihydroxy-hexahydro-2h-1,3-benzodioxol-5-yl]-3-(4-{[(2s,3r,4r,5r)-5-acetyl-3,4-dihydroxyoxolan-2-yl]oxy}-3-hydroxyphenyl)-2-methylprop-2-enimidic acid

C23H29NO12 (511.169)